Show results for
Refine by
Brain Tumours Services
6 services found
by:Omniscient Neurotechnology Pty. Ltd. (o8t) based inHaymarket, AUSTRALIA
As a neurosurgeon, you get one chance to get it right. Each incision is a trade-off between functional impact and therapeutic benefit. Yet, finding that balance remains an elusive task in an organ of such complexity. ...
by:veriNOS pharmaceuticals GmbH based inWuerzburg, GERMANY
Ronopterin – treatment to reduce peritumoral brain edema and improve patient outcomes. Adequate pharmacologic control of peritumoral edema in glioblastoma and brain metastases is still insufficient and is limited by side effects in more than 50% of the patients. ...
Manufactured by:Neurodigitech, LLC based inEncinitas, CALIFORNIA (USA)
The NDT teams in specialized in both non-GLP and GLP compliant pre-clinical assessments of CNS disease therapeutics using a variety of biomarkers, including histology, immunohistochemical and histochemical methods. In particular, NDT is dedicated to custom-designed neuropathological assessments for the neurodegenerative diseases, such as Alzheimer's, Parkinson's, ALS, and brain insults (strokes ...
by:Lena Biosciences, Inc. based inAtlanta, GEORGIA (US) (USA)
We routinely run assays with primary cells and iPSC-derived cells. Organ models: liver, brain, blood and tumors. Normal tissue models: 3D cell-based culture and co-culture models. Tumors: lung, breast, liver etc. We can test small molecules and biologics with tissue slices, and organoids, and maintain cell diversity in the unaltered patient tissue. Cell-based assays are run in our proprietary ...
by:SonALAsense based inBerkeley, CALIFORNIA (USA)
We are committed to providing hope in the face of despair with a unique proprietary non-invasive drug-device combination therapy, ALA Sonodynamic Therapy (SDT), for the treatment of recurrent glioblastoma multiforme (rGBM). ...
by:MtoZ Biolabs based in, MASSACHUSETTS (USA)
To accelerate the development of cancer immunotherapy, it is essential to systematically identify tumor antigens that are truly tumor-specific, patient-shared, stably expressed (i. e., cloned) and immunogenic in all malignant cells. Immunopeptidomics is a large-scale and in-depth approach capable of identifying and quantifying the presented human leukocyte antigen (HLA) immunopeptidome. ...